GO:0048633 positive regulation of skeletal muscle tissue growth: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048633 describes any process that activates, maintains, or increases the rate of skeletal muscle growth, encompassing both myofiber hypertrophy and myonuclear accretion.
• The term is a biological process node that integrates upstream signals such as mechanical load, nutrients, and hormones with downstream effectors including mTORC1, MyoD, and myogenin [1,3,4].
• Key positive regulators include IGF-1, testosterone, beta-adrenergic agonists, and the amino acid leucine, which converge on mTORC1 to drive protein synthesis [1,3,4].
• MyoD and MyoG are core myogenic regulatory factors whose expression is required for satellite cell activation and differentiation during muscle growth.
• Dysregulation of this process contributes to sarcopenia, cachexia, and muscular dystrophies, making it a therapeutic target [1,7].
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of candidate regulators in myoblasts and animal models [5,6].
Description
Skeletal muscle tissue growth is a fundamental biological process that determines muscle mass, strength, and metabolic health. The Gene Ontology term GO:0048633, positive regulation of skeletal muscle tissue growth, captures any process that activates, maintains, or increases the rate of skeletal muscle growth. This term is essential for researchers studying muscle development, regeneration, and diseases characterized by muscle wasting or hypertrophy. Understanding its molecular underpinnings has broad implications for aging, metabolic disease, and regenerative medicine [1,7]. The process is orchestrated by a complex interplay of signaling pathways, transcription factors, and metabolic cues that respond to mechanical load, nutrients, and hormones [1,3,4]. Key anabolic signals such as insulin-like growth factor 1 (IGF-1), testosterone, and amino acids like leucine promote muscle protein synthesis and satellite cell activation, while myogenic regulatory factors such as MyoD and myogenin drive differentiation and fusion [1,6]. Recent studies have also highlighted the role of autophagy, m6A RNA methylation, and myokines in fine-tuning muscle growth [5,6,8]. This article provides a comprehensive overview of GO:0048633, covering its definition, biological mechanisms, key genes, disease relevance, and experimental approaches for investigation.
positive regulation of skeletal muscle tissue growth At A Glance
| GO ID | GO:0048633 |
|---|---|
| GO term | positive regulation of skeletal muscle tissue growth |
| Ontology | biological_process |
| Synonym | activation of skeletal muscle growth; stimulation of skeletal muscle growth; up regulation of skeletal muscle growth; up-regulation of skeletal muscle growth; upregulation of skeletal muscle growth |
| Major function | Increases the rate, extent, or maintenance of skeletal muscle tissue growth |
| Related processes | mTOR signaling, myogenesis, satellite cell activation, protein synthesis |
| Key regulators | IGF-1, testosterone, leucine, MyoD, myogenin, mTORC1 |
| Disease relevance | Sarcopenia, cachexia, muscular dystrophy, metabolic disorders |
What Is GO:0048633?
GO:0048633 is defined as any process that activates, maintains or increases the rate of skeletal muscle growth. It is a biological process term that encompasses positive regulation at the cellular, tissue, and organismal levels, including signals that promote myofiber hypertrophy, satellite cell proliferation and differentiation, and myonuclear accretion.
Why Is positive regulation of skeletal muscle tissue growth Important in Cell Biology?
GO:0048633 is critical because skeletal muscle mass is a major determinant of whole-body metabolism, physical function, and quality of life. Positive regulation of muscle growth underlies adaptations to exercise and nutrition, and its failure contributes to sarcopenia, cachexia, and muscular dystrophies [1,7]. Understanding this process informs strategies to combat muscle wasting and to enhance muscle repair in clinical settings [4,7].
• Skeletal muscle is the largest protein reservoir in the body and a key regulator of glucose homeostasis [1,7].
• Positive regulation of muscle growth is essential for recovery from injury and for maintaining mobility with aging [1,4].
• Dysregulation leads to sarcopenia, cachexia, and muscle atrophy in chronic diseases [1,7].
• Muscle growth is modulated by exercise, nutrition, and hormones, making it a target for therapeutic intervention [3,4].
• Myokines secreted by growing muscle influence appetite, inflammation, and systemic metabolism.
• Understanding GO:0048633 aids in developing treatments for muscular dystrophies and age-related muscle loss.
• It is central to livestock production and meat quality research.
• It provides a framework for studying stem cell biology and tissue regeneration.
• It links to autophagy and RNA methylation pathways that fine-tune muscle mass [5,6].
• It is a key area for CRISPR-based functional genomics and drug discovery [5,6].
What Happens During positive regulation of skeletal muscle tissue growth?
Initiation by Anabolic Signals
In simple terms: Muscle growth starts when signals like exercise, nutrients, or hormones tell the muscle to build more protein.
Positive regulation of skeletal muscle growth is initiated by mechanical loading, amino acids (especially leucine), and hormones such as IGF-1 and testosterone. These signals activate upstream kinases including PI3K/Akt and mTORC1, which promote protein synthesis and inhibit proteolysis [1,3,4]. Exercise and protein intake are potent stimuli that increase muscle protein synthesis and net growth [3,4].
Satellite Cell Activation and Proliferation
In simple terms: Stem cells in muscle wake up and multiply to provide new nuclei for growing fibers.
Muscle satellite cells are resident stem cells that become activated in response to growth stimuli. They proliferate and then differentiate to fuse with existing myofibers, donating nuclei that support hypertrophy [1,6]. MyoD is a key transcription factor required for satellite cell activation and differentiation, and its expression is regulated by m6A methylation in response to exercise.
Myogenic Differentiation and Fusion
In simple terms: The multiplied cells turn into muscle cells and merge with existing fibers.
Activated satellite cells express myogenic regulatory factors such as MyoD and myogenin, which drive differentiation into myoblasts. These myoblasts then fuse with each other or with existing myofibers, a process dependent on membrane proteins and cytoskeletal remodeling. Autophagy, regulated by AMPK/ULK1, also supports myoblast differentiation and muscle regeneration.
Protein Synthesis and Hypertrophy
In simple terms: The muscle fiber increases in size by making more proteins and adding sarcomeres.
mTORC1 activation leads to phosphorylation of downstream targets such as p70S6K and 4E-BP1, enhancing translation initiation and protein synthesis. This results in increased myofibrillar protein content and cross-sectional area of myofibers [1,3]. Dietary protein and resistance exercise synergistically stimulate this pathway [3,4].
Metabolic and Systemic Modulation
In simple terms: Muscle growth is influenced by whole-body metabolism and signals from other organs.
Myokines secreted by muscle, such as IL-6 and irisin, can modulate systemic metabolism and appetite, creating a feedback loop that influences muscle growth [7,8]. Additionally, autophagy and mitochondrial function are integrated with growth signals to maintain muscle quality.
Key Genes Involved in GO:0048633 positive regulation of skeletal muscle tissue growth
The following genes and proteins are central to the positive regulation of skeletal muscle tissue growth, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IGF1 | Anabolic hormone that activates PI3K/Akt/mTORC1 | Key mediator of muscle hypertrophy; knockout models show growth retardation |
| MSTN | Negative regulator of muscle growth (myostatin) | Inhibition or knockout leads to muscle hyperplasia/hypertrophy |
| MYOD1 | Myogenic regulatory factor; drives satellite cell activation and differentiation | Essential for myogenesis; regulated by m6A methylation |
| MYOG | Myogenin; promotes terminal differentiation and fusion | Marker of differentiation; knockout causes severe muscle defects |
| AKT1 | Serine/threonine kinase; promotes protein synthesis and inhibits atrophy | Central node in hypertrophy signaling; overexpression induces hypertrophy |
| MTOR | Kinase; master regulator of protein synthesis | Target of rapamycin; integrates nutrient and growth factor signals [1,3] |
| AMPK | Energy sensor; regulates autophagy and metabolism | Modulates muscle growth via ULK1 and autophagy |
| ULK1 | Autophagy-initiating kinase | Required for myoblast differentiation and regeneration |
| PBK | Serine/threonine kinase; positively regulates myoblast differentiation | Enhances AMPK/ULK1-mediated autophagy; knockout impairs regeneration |
| METTL3 | m6A methyltransferase | Regulates MyoD mRNA stability in satellite cells during exercise-induced growth |
| FOXO1 | Transcription factor; promotes atrophy genes | Inhibited by Akt; nuclear export prevents atrophy |
| MYF5 | Myogenic factor; specifies myoblast fate | Required for satellite cell commitment |
| PAX7 | Paired box transcription factor; maintains satellite cell pool | Marker of quiescent satellite cells; essential for self-renewal |
| IL6 | Myokine; modulates inflammation and metabolism | Secreted during exercise; affects muscle growth and systemic energy balance |
| FNDC5 | Precursor of irisin; myokine | Influences adipose tissue and muscle metabolism |
| LEP | Leptin; regulates appetite and energy balance | Links muscle mass to appetite control |
| IGF1R | Receptor for IGF-1 | Mediates IGF-1 signaling to Akt/mTOR |
| TESTOSTERONE | Steroid hormone (not a gene) | Promotes muscle protein synthesis and satellite cell activation |
How Is positive regulation of skeletal muscle tissue growth Regulated?
Positive regulation of skeletal muscle tissue growth is controlled by a network of signaling pathways. The IGF-1/PI3K/Akt/mTORC1 axis is a central anabolic pathway that promotes protein synthesis and inhibits FOXO-mediated atrophy. Mechanical loading and amino acids, particularly leucine, activate mTORC1 independently of IGF-1 [3,4]. Myostatin, a TGF-beta family member, negatively regulates muscle growth and its inhibition leads to hypertrophy. AMPK acts as an energy sensor that can inhibit mTORC1 but also supports autophagy required for differentiation. Epigenetic regulation, such as m6A methylation of MyoD mRNA by METTL3, modulates satellite cell function in response to exercise. Systemic factors including testosterone, beta-adrenergic agonists, and myokines further fine-tune the growth response [1,8].
positive regulation of skeletal muscle tissue growth and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MSTN | Muscle hypertrophy; myostatin-related muscle overgrowth | Knockout mouse or CRISPR knockout in myoblasts |
| IGF1 | Sarcopenia; muscle wasting | Overexpression or knock-in in muscle tissue |
| MYOD1 | Muscle regeneration defects | Point mutation or knockout in satellite cells |
| METTL3 | Impaired exercise-induced muscle growth | Conditional knockout in muscle stem cells |
| PBK | Defective muscle regeneration | Knockout and overexpression in myoblasts |
Sarcopenia and Age-Related Muscle Loss
Sarcopenia is characterized by progressive loss of muscle mass and strength with aging. Impaired positive regulation of muscle growth, including reduced satellite cell function and anabolic resistance, contributes to sarcopenia [1,7]. Interventions that enhance muscle protein synthesis, such as resistance exercise and leucine supplementation, are mainstays of management.
Cachexia and Chronic Disease
Cachexia is a complex metabolic syndrome associated with cancer, chronic heart failure, and other diseases, leading to severe muscle wasting. It results from an imbalance between protein synthesis and degradation, with increased catabolic signaling and blunted anabolic responses [1,7]. Targeting positive regulators of muscle growth, such as IGF-1 or mTOR, is a therapeutic strategy under investigation.
Muscular Dystrophies
Duchenne muscular dystrophy and related disorders are caused by mutations in structural proteins, leading to progressive muscle degeneration. Enhancing muscle growth and regeneration through modulation of pathways like IGF-1/Akt or inhibition of myostatin is being explored as a treatment approach.
Metabolic Disorders
Skeletal muscle is a major site of glucose disposal, and muscle growth is associated with improved insulin sensitivity. Conditions such as type 2 diabetes and obesity are linked to impaired muscle growth and function [7,8]. Myokines released during muscle growth can influence appetite and energy balance, highlighting the systemic impact of GO:0048633 [7,8].
From positive regulation of skeletal muscle tissue growth-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X promote myoblast differentiation? | CRISPR knockout and overexpression in C2C12 myoblasts |
| Does gene X regulate satellite cell activation in vivo? | Conditional knockout in Pax7-CreERT2 mice |
| Does a point mutation in gene X affect protein function? | Knock-in of point mutation using CRISPR |
| Does gene X enhance muscle hypertrophy? | Overexpression via AAV in mouse muscle |
| Does gene X interact with mTORC1? | Tagged knock-in for co-IP and proteomics |
| Does gene X affect exercise-induced m6A methylation? | Knockout of METTL3 in muscle stem cells |
How to Study the positive regulation of skeletal muscle tissue growth Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify pathways altered during muscle growth |
| m6A-seq | RNA methylation sites | Study epitranscriptomic regulation of MyoD |
| Proteomics | Protein abundance and modifications | Quantify mTORC1 targets and myofibrillar proteins |
| CRISPR screen | Gene function at scale | Discover novel regulators of myoblast differentiation |
| Immunofluorescence | Protein localization and differentiation markers | Assess myotube formation and fusion |
| Western blot | Protein expression and phosphorylation | Measure Akt/mTOR signaling |
| Histology | Muscle fiber size and morphology | Evaluate hypertrophy in animal models |
| Autophagy flux assay | Autophagic activity | Study AMPK/ULK1 role in differentiation |
Transcriptomic and Epitranscriptomic Profiling
RNA-seq and m6A-seq can identify changes in gene expression and RNA methylation during muscle growth. For example, exercise-induced m6A methylation of MyoD mRNA in satellite cells was discovered using these methods.
Proteomic and Phosphoproteomic Analysis
Mass spectrometry-based proteomics can quantify changes in protein synthesis and phosphorylation of mTORC1 targets such as p70S6K and 4E-BP1, providing insights into anabolic signaling [1,3].
Functional Genomics with CRISPR Screens
Genome-wide CRISPR knockout or activation screens in myoblasts can identify novel regulators of differentiation and growth. These screens are powerful for discovering genes that positively or negatively regulate GO:0048633.
Imaging and Histology
Immunofluorescence for myosin heavy chain, MyoD, and myogenin, combined with EdU incorporation, allows assessment of differentiation and fusion indices. In vivo, muscle cross-sectional area and fiber type can be measured by histology [1,6].
How CRISPR Can Be Used to Study GO:0048633 positive regulation of skeletal muscle tissue growth
Knockout
CRISPR knockout of candidate positive regulators (e.g., PBK, METTL3) in myoblasts or satellite cells can determine their necessity for muscle growth. For example, Pbk knockout impaired myoblast differentiation and muscle regeneration in mice, and Mettl3 knockout in satellite cells reduced exercise-induced muscle growth.
Point Mutation
Introducing precise point mutations (e.g., in kinase domains of PBK or AMPK) can dissect signaling mechanisms. This approach helps distinguish between catalytic and scaffolding functions.
Knock-in
Knock-in of tags (e.g., FLAG, GFP) or reporter genes allows visualization and purification of proteins involved in muscle growth. Knock-in of disease-associated mutations can model human conditions.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of genes like IGF1 or PBK can test sufficiency for inducing hypertrophy. Overexpression of Pbk enhanced myoblast differentiation via AMPK/ULK1-mediated autophagy.
How EDITGENE Supports positive regulation of skeletal muscle tissue growth Research
Researchers studying positive regulation of skeletal muscle tissue growth-related genes often need to determine whether a candidate gene is causally involved in myogenesis, hypertrophy, or regeneration. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of skeletal muscle tissue growth research.
Frequently Asked Questions About positive regulation of skeletal muscle tissue growth
What is GO:0048633?
GO:0048633 is a Gene Ontology term for any process that activates, maintains or increases the rate of skeletal muscle growth.
What genes are involved in positive regulation of skeletal muscle tissue growth?
Key genes include IGF1, MSTN, MYOD1, MYOG, AKT1, MTOR, AMPK, ULK1, PBK, and METTL3, among others [1,5,6].
How does mTOR regulate muscle growth?
mTORC1 integrates signals from IGF-1, amino acids, and mechanical load to promote protein synthesis and inhibit atrophy [1,3].
What is the role of satellite cells in muscle growth?
Satellite cells are muscle stem cells that activate, proliferate, and fuse with myofibers to support growth and repair [1,6].
How does exercise promote muscle growth?
Exercise increases mechanical load and activates anabolic signaling, including mTORC1 and m6A methylation of MyoD, leading to protein synthesis and satellite cell activation [3,6].
What diseases are associated with impaired muscle growth?
Sarcopenia, cachexia, muscular dystrophies, and metabolic disorders are linked to dysregulated muscle growth [1,7].
Can CRISPR be used to study muscle growth?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to study gene function in myoblasts and animal models [5,6].
What is the role of myostatin in muscle growth?
Myostatin is a negative regulator; its inhibition or knockout leads to increased muscle mass.
How does autophagy contribute to muscle growth?
Autophagy, regulated by AMPK/ULK1, supports myoblast differentiation and regeneration.
What are myokines and how do they relate to muscle growth?
Myokines are cytokines secreted by muscle that can influence systemic metabolism and appetite, linking muscle growth to whole-body physiology [7,8].
Conclusion
GO:0048633, positive regulation of skeletal muscle tissue growth, is a central biological process that integrates anabolic signals, myogenic transcription factors, and metabolic cues to control muscle mass. Its dysregulation underlies major diseases such as sarcopenia and cachexia, making it a prime target for therapeutic intervention. Advances in CRISPR-based models and multi-omics approaches are rapidly expanding our understanding of this process, offering new opportunities for drug discovery and regenerative medicine.
References
- 1. Schiaffino S et al.. 2013. Mechanisms regulating skeletal muscle growth and atrophy.. FEBS J 280(17):4294-314 PMID: 23517348
- 3. Tipton KD et al.. 2001. Exercise, protein metabolism, and muscle growth.. Int J Sport Nutr Exerc Metab 11(1):109-32 PMID: 11255140
- 4. Carbone JW et al.. 2019. Dietary Protein and Muscle Mass: Translating Science to Application and Health Benefit.. Nutrients 11(5) PMID: 31121843
- 5. Wang D et al.. 2025. Pbk positively regulates myoblast differentiation and muscle regeneration via enhancing AMPK/ULK1 mediated myogenic autophagy.. J Transl Med 23(1):1144 PMID: 41121382
- 6. Feng S et al.. 2024. Exercise promotes skeletal muscle growth in adolescents via modulating Mettl3-mediated m6A methylation of MyoD in muscle satellite cells.. Cell Mol Biol Lett 29(1):150 PMID: 39633280
- 7. Grannell A et al.. 2019. The influence of skeletal muscle on appetite regulation.. Expert Rev Endocrinol Metab 14(4):267-282 PMID: 31106601
- 8. Barbalho SM et al.. 2020. Myokines: a descriptive review.. J Sports Med Phys Fitness 60(12):1583-1590 PMID: 32586076
